Point72 Hong Kong’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
ACA
Point72 Hong Kong's BPMC Position: Q1 2025 in Review
Point72 Hong Kong sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 2,218 shares — an estimated $193K sold.
Point72 Hong Kong first reported a position in BPMC in Q1 2017 and held it in 14 quarters. The position peaked at $360K in Q2 2024. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.
- Point72 Hong Kong reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
- Point72 Hong Kong sold 2,218 Blueprint Medicines shares in Q1 2025, an estimated $193K.
- Point72 Hong Kong first reported a position in Blueprint Medicines in Q1 2017 and held it in 14 quarters.
- Point72 Hong Kong's Blueprint Medicines position peaked at $360K in Q2 2024.
- 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.
Based on Point72 Hong Kong's 13F filing for Q1 2025, filed 15 May 2025.